glp-1 gi obstruction lawsuit in kentucky gastrointestinal legal team Zepbound [2026] glp-1 gastroparesis law office in

Tirzepatide / Niacinamide Injection may cause various side effects ranging from common, generally mild reactions to rare but potentially serious adverse events

These effects typically subside as your body adapts to the medication, though they may persist in 1015% of patients

In the STEP-1 trial, 1,961 patients were followed for 68 weeks and underwent randomization to semaglutide or placebo plus lifestyle intervention resulting in14.9% weight loss in the semaglutide group versus 2.5% in the placebo group [33]

These peptides then increase intestinal glucose-6-phosphotase, ultimately leading to activation of a portal glucose sensor that signals to the brain 59

This is why GLP-1 integration at The Meadows is selective, individualized, and grounded in multidisciplinary evaluation

In the STEP 13 clinical trials conducted between 2018 and 2020, semaglutide was shown to significantly reduce inflammatory markers